Evolent Health Inc. (EVH)
NYSE: EVH
· Real-Time Price · USD
9.22
0.40 (4.54%)
At close: Aug 15, 2025, 2:57 PM
Evolent Health Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 2.2B | 2.4B | 2.55B | 2.46B | 2.35B | 2.18B | 1.96B | 1.79B | 1.63B | 1.48B | 1.35B | 1.22B | 1.09B | 989.94M | 907.96M | 931.52M | 973.64M | 990.22M |
Cost of Revenue | 1.84B | 2.06B | 2.25B | 2.13B | 1.98B | 1.76B | 1.5B | 1.35B | 1.23B | 1.13B | 1.04B | 900.54M | 797.05M | 719.46M | 657.55M | 669.81M | 689.85M | 683.55M |
Gross Profit | 336.12M | 335.55M | 307.68M | 333.6M | 377.33M | 417.86M | 460.47M | 441.91M | 403.44M | 356.48M | 316.58M | 317.4M | 290.77M | 270.49M | 250.41M | 261.71M | 283.79M | 306.67M |
Operating Income | -37.66M | -28.7M | -21.25M | -24M | -25.67M | -55.03M | -62.64M | -60.87M | -29.98M | -9.77M | -3.82M | 3.55M | -15.98M | -22.3M | -42.41M | -34.93M | -46.06M | -265.86M |
Interest Income | 3.98M | 4.27M | 5.54M | 7.24M | 7.51M | 6.75M | 5.26M | 3.34M | 2.69M | 2.31M | 1.37M | 861K | 556K | 401K | 407K | 426K | 1.47M | 2.1M |
Pretax Income | -131.55M | -109.47M | -63.04M | -87.18M | -94.3M | -130.95M | -202.41M | -164.56M | -177.08M | -146.1M | -62.08M | -49.25M | -18.66M | -23.37M | -29.8M | -46.63M | -71.49M | -269.9M |
Net Income | -161.65M | -108.96M | -61.62M | -72.23M | -74.42M | -110.34M | -113.04M | -90.98M | -63.53M | -33.33M | -18.7M | -13M | -28.16M | -33.14M | -37.6M | -46.58M | -70.89M | -265.3M |
Selling & General & Admin | 268.38M | 260.38M | 250.75M | 284.48M | 313.99M | 337.16M | 358.11M | 359.54M | 331.5M | 300.06M | 269.27M | 253.32M | 236.1M | 219.84M | 219.5M | 239.03M | 264.82M | 290.78M |
Research & Development | n/a | 6.7M | 13M | 19.6M | 26.2M | 26.3M | 26.7M | 27.5M | 27.3M | 24.3M | 21.7M | 20.8M | 21.1M | 23.9M | 29.9M | 45M | 44.5M | 43.9M |
Other Expenses | 128.54M | 127.33M | 144.09M | 132.43M | 141.73M | 116.56M | 103.4M | 88.23M | 5.82M | 20.95M | 6.78M | 9.9M | 53.07M | 37.94M | 45.79M | 22.61M | 22.54M | 22.91M |
Operating Expenses | 396.92M | 394.42M | 407.84M | 436.51M | 481.92M | 505.38M | 506.87M | 486.53M | 429.88M | 381.43M | 336.46M | 315.81M | 296.25M | 279.8M | 279.54M | 298.86M | 324.48M | 351.3M |
Interest Expense | 34.72M | 29.11M | 24.72M | 30.24M | 38.84M | 47.31M | 54.2M | 48.4M | 38.54M | 26.23M | 15.57M | 15.59M | 17.2M | 21.33M | 25.43M | 27.32M | 28.37M | 28.38M |
Selling & Marketing Expenses | n/a | n/a | -10.33M | -10.33M | -10.33M | -10.33M | n/a | -35.03M | -35.03M | -35.03M | -35.03M | -34.37M | -34.37M | -34.37M | -34.37M | n/a | n/a | n/a |
Cost & Expenses | 2.23B | 2.43B | 2.59B | 2.51B | 2.4B | 2.23B | 2.01B | 1.83B | 1.66B | 1.51B | 1.37B | 1.22B | 1.09B | 999.25M | 937.09M | 968.67M | 1.01B | 1.03B |
Income Tax Expense | -1.09M | -508K | -1.41M | -14.95M | -19.88M | -20.61M | -89.36M | -73.59M | -113.55M | -112.77M | -43.38M | -44.95M | 799K | 1.07M | 483K | 514K | 783K | -3.21M |
Shares Outstanding (Basic) | 115.88M | 115.31M | 115.03M | 114.86M | 114.69M | 114.14M | 113.59M | 112.28M | 111.28M | 107.78M | 99.8M | 95.29M | 90.07M | 89.51M | 88.33M | 85.8M | 85.45M | 84.67M |
Shares Outstanding (Diluted) | 115.88M | 115.31M | 115.03M | 114.86M | 114.69M | 114.14M | 113.59M | 112.28M | 111.28M | 107.78M | 99.8M | 99.31M | 90.07M | 89.51M | 88.33M | 85.8M | 85.45M | 84.67M |
EPS (Basic) | -1.61 | -1.23 | -0.82 | -0.91 | -0.94 | -1.19 | -1.16 | -0.91 | -0.59 | -0.33 | -0.2 | -0.15 | -0.32 | -0.38 | -0.44 | -0.55 | -0.84 | -3.11 |
EPS (Diluted) | -1.61 | -1.23 | -0.82 | -0.91 | -0.94 | -1.19 | -1.16 | -0.91 | -0.59 | -0.33 | -0.2 | -0.15 | -0.32 | -0.38 | -0.44 | -0.55 | -0.84 | -3.11 |
EBITDA | 10.56M | 36.98M | 84.47M | 64.95M | 71.48M | 45.72M | -16.78M | 5.43M | -32.91M | -34.64M | 22.27M | 30.41M | 58.69M | 63.17M | 63.97M | 49.43M | 31.12M | -167.01M |
EBIT | -96.83M | -80.36M | -21.77M | -40.39M | -38.91M | -67.1M | -148.2M | -116.17M | -138.55M | -119.87M | -46.51M | -33.66M | -1.46M | -2.04M | -4.38M | -19.31M | -43.12M | -240M |
Depreciation & Amortization | 107.39M | 115.23M | 120.68M | 119.79M | 124.83M | 129.36M | 131.42M | 129.89M | 112.35M | 91.94M | 75.48M | 62.49M | 60.15M | 65.21M | 68.35M | 68.14M | 67.97M | 63.58M |